NCT06179641

Brief Summary

The objective of this clinical trial is to compare two regional analgesia techniques in patients undergoing total knee arthroplasty: IPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) vs selective tibial nerve block. The main question is whether one of these peripheral blocks is more effective in reducing postoperative pain than the other. All patients will have a spinal block with an adductor canal block. One group will receive an IPACK block and the other group, a selective tibial nerve block. Postoperative pain scores and morphine consumption, among others, will be compared between groups.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 22, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 8, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2025

Completed
Last Updated

February 9, 2024

Status Verified

February 1, 2024

Enrollment Period

1.4 years

First QC Date

November 30, 2023

Last Update Submit

February 8, 2024

Conditions

Keywords

nerve blockpain managementpostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Total iv morphine consumption

    consumption in mg

    24 hours postoperatively

Secondary Outcomes (12)

  • Morphine consumption in the recovery room

    From admission till discharge from the recovery room, up to 2 hours

  • PCA administered morphine consumption

    at day 1, day 2 and day 3 postoperatively

  • rest and dynamic pain scores

    at day 1, day 2 and day 3 postoperatively

  • Duration of peripheral nerve block

    From execution of a peripheral nerve block till administration of a first dose of iv morphine, up to 48 hours

  • Incidence of postoperative nausea and vomiting

    at day 1, day 2 and day 3 postoperatively

  • +7 more secondary outcomes

Study Arms (2)

IPACK group

ACTIVE COMPARATOR

IPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) block

Procedure: IPACK block

Tibial nerve group

EXPERIMENTAL

selective tibial nerve block

Procedure: Selective tibial nerve block

Interventions

The selective tibial nerve block will be performed on the popliteal crease following sterilization of the area. The probe will be placed in a transverse position at the popliteal crease to visualize the popliteal artery and the tibial nerve in short axis. A 21-gauge 50mm insulated facet tip needle (SonoPlex® STIM, Pajunk, Geisingen, DE) will be inserted in-plane with the ultrasound bean from a medial to lateral direction. Once the needle tip is adjacent to the tibial nerve, 5 ml of ropivacaine 0.75% will be injected to achieve an adequate spread of local anesthetics around the nerve.

Tibial nerve group
IPACK blockPROCEDURE

The IPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) will be performed on the popliteal crease following sterilization of the area. The probe will be placed in a transverse position proximal to the popliteal crease to visualize the popliteal artery in short axis. A 21-gauge 100 mm insulated facet tip needle (SonoPlex® STIM, Pajunk, Geisingen, DE) will be inserted in-plane with the ultrasound beam, in a lateral to medial direction, between the popliteal artery and the posterior capsule, where nineteen mL of ropivacaine 0.2% will be injected under ultrasound guidance. The distribution of local anesthetics will be observed above the posterior capsule.

IPACK group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists classification I-III
  • yo or older
  • patients scheduled for total knee arthroplasty under central spinal anesthesia
  • informed consent signed

You may not qualify if:

  • Refusal or inability for informed consent
  • Known allergies to ropivacaine, acetaminophen, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone
  • Secondary surgical revision
  • Opioid treatment such as morphine, hydrocodone, hydromorphone, tramadol, methadone, fentanyl, buprenorphine or codeine
  • Bleeding diathesis
  • Neurological deficit
  • Known renal insufficiency (eGFR \<45 ml/min)
  • Known hepatic insufficiency (Child score B or C)
  • Alcohol abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Lausanne

Lausanne, Canton of Vaud, 1011, Switzerland

RECRUITING

Related Publications (8)

  • Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998 Jul;87(1):88-92. doi: 10.1097/00000539-199807000-00019.

    PMID: 9661552BACKGROUND
  • Scott CE, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br. 2010 Sep;92(9):1253-8. doi: 10.1302/0301-620X.92B9.24394.

    PMID: 20798443BACKGROUND
  • Williams DP, O'Brien S, Doran E, Price AJ, Beard DJ, Murray DW, Beverland DE. Early postoperative predictors of satisfaction following total knee arthroplasty. Knee. 2013 Dec;20(6):442-6. doi: 10.1016/j.knee.2013.05.011. Epub 2013 Jun 16.

    PMID: 23777807BACKGROUND
  • Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010 Jan;468(1):57-63. doi: 10.1007/s11999-009-1119-9.

    PMID: 19844772BACKGROUND
  • van der Wal M, Lang SA, Yip RW. Transsartorial approach for saphenous nerve block. Can J Anaesth. 1993 Jun;40(6):542-6. doi: 10.1007/BF03009739.

    PMID: 8403121BACKGROUND
  • Fischer HB, Simanski CJ, Sharp C, Bonnet F, Camu F, Neugebauer EA, Rawal N, Joshi GP, Schug SA, Kehlet H; PROSPECT Working Group. A procedure-specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia. 2008 Oct;63(10):1105-23. doi: 10.1111/j.1365-2044.2008.05565.x. Epub 2008 Jul 10.

    PMID: 18627367BACKGROUND
  • Silverman ER, Vydyanathan A, Gritsenko K, Shaparin N, Singh N, Downie SA, Kosharskyy B. The Anatomic Relationship of the Tibial Nerve to the Common Peroneal Nerve in the Popliteal Fossa: Implications for Selective Tibial Nerve Block in Total Knee Arthroplasty. Pain Res Manag. 2017;2017:7250181. doi: 10.1155/2017/7250181. Epub 2017 Feb 2.

    PMID: 28260964BACKGROUND
  • Paulou F, Wegrzyn J, Rossel JB, Gonvers E, Antoniadis A, Kagi M, Wolmarans MR, Lambert J, Albrecht E. Analgesic efficacy of selective tibial nerve block versus partial local infiltration analgesia for posterior pain after total knee arthroplasty: a randomized, controlled, triple-blinded trial. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101223. doi: 10.1016/j.accpm.2023.101223. Epub 2023 Apr 6.

    PMID: 37030393BACKGROUND

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Central Study Contacts

Marta Szyszko du Bois d'Aische

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
quadruple
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: single centered, prospective, randomized double blinded controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Med. Eric Albrecht

Study Record Dates

First Submitted

November 30, 2023

First Posted

December 22, 2023

Study Start

February 8, 2024

Primary Completion

July 12, 2025

Study Completion

July 18, 2025

Last Updated

February 9, 2024

Record last verified: 2024-02

Locations